HUM FINANCIAL STATEMENTS

Humana Inc — balance sheet, income statement and cash flow trends

HUMHumana Inc

🇺🇸 USA · US · Healthcare · Healthcare Plans

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue137.2 B $+14.1%

Gross Profit19.2 B $+5.7%

Operating Income1.4 B $-39.4%

EBITDA2.9 B $-26.7%

Net Income1.1 B $-33.9%

Peer Comparison· Healthcare Plans

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
HUM	14.1%	14.0%	2.1%	0.8%
SHL	-0.3%	38.0%	19.1%	9.1%
BAYN	-2.9%	59.3%	7.7%	-4.8%
MRK	-1.7%	58.5%	28.5%	12.1%
AZN	9.9%	81.6%	33.7%	17.2%
CSL	4.8%	48.6%	32.8%	9.2%
Industry median	9.6%	14.5%	2.4%	0.8%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
HUM	14.1%	14.0%	2.1%	0.8%
CNC	17.0%	14.9%	-2.2%	-3.3%
CI	8.8%	9.3%	4.4%	2.3%
ELV	9.4%	23.2%	4.4%	2.6%
CVS	7.6%	13.9%	2.7%	0.7%
MOH	7.7%	8.5%	1.4%	0.4%
Industry median	9.6%	14.5%	2.4%	0.8%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity18.6 B $34%
Current Liabilities21.5 B $39%
Long-term Liabilities15.1 B $27%

Key Figures

YoY change

Total Assets55.3 B $+8.5%

Total Liabilities36.6 B $+10.6%

Total Equity18.6 B $+4.7%

Cash & ST Investments22 B $+416.8%

Total Debt14 B $+5.2%

Net Debt9 B $-0.2%

Peer Comparison· Healthcare Plans

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
HUM	1.26	75.3%	-2.80	33.6%
SHL	1.10	84.1%	3.04	40.6%
BAYN	1.06	134.8%	9.19	26.7%
MRK	1.51	40.5%	1.38	56.0%
AZN	0.91	71.7%	1.29	41.5%
CSL	2.57	67.4%	2.22	49.2%
Industry median	1.19	75.2%	-1.10	29.1%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
HUM	1.26	75.3%	-2.80	33.6%
CNC	1.12	76.4%	1.66	26.4%
CI	0.82	73.2%	1.89	27.5%
ELV	1.48	72.5%	-0.42	34.9%
CVS	0.87	101.1%	5.98	30.6%
MOH	1.63	96.7%	-8.60	24.9%
Industry median	1.19	75.2%	-1.10	29.1%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow1.8 B $-35.8%

Capital Expenditures572 M $+16.0%

Free Cash Flow1.3 B $-46.6%

Dividends Paid-429 M $-199.8%

Peer Comparison· Healthcare Plans

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
HUM	1.3%	0.9%	0.4%	163.2%
SHL	12.2%	8.7%	3.5%	134.0%
BAYN	10.0%	4.4%	5.5%	-209.8%
MRK	20.0%	11.5%	8.5%	165.6%
AZN	23.5%	14.5%	9.0%	136.9%
CSL	24.0%	20.3%	3.7%	261.5%
Industry median	3.7%	3.2%	0.5%	176.5%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
HUM	1.3%	0.9%	0.4%	163.2%
CNC	3.6%	3.2%	0.4%	-111.4%
CI	3.2%	2.8%	0.4%	140.1%
ELV	3.8%	3.2%	0.6%	145.1%
CVS	2.5%	1.8%	0.7%	352.4%
MOH	0.8%	0.6%	0.2%	189.9%
Industry median	3.7%	3.2%	0.5%	176.5%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on HUM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.